These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 10694190

  • 21. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
    Fedorova OV, Simbirtsev AS, Kolodkin NI, Kotov AY, Agalakova NI, Kashkin VA, Tapilskaya NI, Bzhelyansky A, Reznik VA, Frolova EV, Nikitina ER, Budny GV, Longo DL, Lakatta EG, Bagrov AY.
    J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
    [Abstract] [Full Text] [Related]

  • 22. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats.
    Bagrov AY, Agalakova NI, Kashkin VA, Fedorova OV.
    Am J Hypertens; 2009 May; 22(5):559-63. PubMed ID: 19229192
    [Abstract] [Full Text] [Related]

  • 23. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY.
    Circulation; 2002 Mar 05; 105(9):1122-7. PubMed ID: 11877366
    [Abstract] [Full Text] [Related]

  • 24. The α2 isoform Na,K-ATPase modulates contraction of rat mesenteric small artery via cSrc-dependent Ca2+ sensitization.
    Bouzinova EV, Hangaard L, Staehr C, Mazur A, Ferreira A, Chibalin AV, Sandow SL, Xie Z, Aalkjaer C, Matchkov VV.
    Acta Physiol (Oxf); 2018 Sep 05; 224(1):e13059. PubMed ID: 29480968
    [Abstract] [Full Text] [Related]

  • 25. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
    Bagrov AY, Roukoyatkina NI, Pinaev AG, Dmitrieva RI, Fedorova OV.
    Eur J Pharmacol; 1995 Feb 14; 274(1-3):151-8. PubMed ID: 7768267
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms of endothelin-1-induced potentiation of noradrenaline response in rat mesenteric artery.
    Matsumura Y, Kita S, Okui T.
    Clin Exp Pharmacol Physiol; 2001 Jul 14; 28(7):540-4. PubMed ID: 11422221
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of low Km cyclic GMP phosphodiesterases and potentiation of guanylate cyclase activators by cicletanine.
    Silver PJ, Buchholz A, Dundore RL, Harris AL, Pagani ED.
    J Cardiovasc Pharmacol; 1990 Sep 14; 16(3):501-5. PubMed ID: 1700224
    [Abstract] [Full Text] [Related]

  • 28. Modulation of arterial Na+-K+-ATPase-induced [Ca2+]i reduction and relaxation by norepinephrine, ET-1, and PMA.
    Pérez-Vizcaíno F, Cogolludo A, Tamargo J.
    Am J Physiol; 1999 Feb 14; 276(2):H651-7. PubMed ID: 9950867
    [Abstract] [Full Text] [Related]

  • 29. Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells.
    Uddin MN, Horvat D, Glaser SS, Danchuk S, Mitchell BM, Sullivan DE, Morris CA, Puschett JB.
    Placenta; 2008 Mar 14; 29(3):266-73. PubMed ID: 18279954
    [Abstract] [Full Text] [Related]

  • 30. Antibody against Na/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia.
    Agalakova NI, Reznik VA, Nadei OV, Ershov IA, Rassokha OS, Vasyutina ML, Ivanov DO, Adair CD, Galagudza MM, Bagrov AY.
    Am J Hypertens; 2020 May 21; 33(6):514-519. PubMed ID: 31713584
    [Abstract] [Full Text] [Related]

  • 31. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells.
    Periyasamy SM, Liu J, Tanta F, Kabak B, Wakefield B, Malhotra D, Kennedy DJ, Nadoor A, Fedorova OV, Gunning W, Xie Z, Bagrov AY, Shapiro JI.
    Kidney Int; 2005 May 21; 67(5):1868-77. PubMed ID: 15840034
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.
    Silver PJ, O'Connor B, Cumiskey WR, Van Aller G, Hamel LT, Bentley RG, Pagani ED.
    J Pharmacol Exp Ther; 1991 Apr 21; 257(1):382-91. PubMed ID: 1850474
    [Abstract] [Full Text] [Related]

  • 33. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV, Lakatta EG, Bagrov AY.
    Circulation; 2000 Dec 12; 102(24):3009-14. PubMed ID: 11113054
    [Abstract] [Full Text] [Related]

  • 34. Action of protein kinase C in endothelin-induced contractions in rat aortic rings.
    Oriji GK, Keiser HR.
    Am J Physiol; 1996 Jul 12; 271(1 Pt 1):C398-404. PubMed ID: 8760071
    [Abstract] [Full Text] [Related]

  • 35. The role of Na(+), K(+)-ATPase in the hypoxic vasoconstriction in isolated rat basilar artery.
    Shen H, Liang P, Qiu S, Zhang B, Wang Y, Lv P.
    Vascul Pharmacol; 2016 Jun 12; 81():53-60. PubMed ID: 26924456
    [Abstract] [Full Text] [Related]

  • 36. Marinobufagenin and cyclic strain may activate endothelial NADPH oxidase, contributing to the adverse impact of salty diets on vascular and cerebral health.
    McCarty MF.
    Med Hypotheses; 2012 Feb 12; 78(2):191-6. PubMed ID: 21968275
    [Abstract] [Full Text] [Related]

  • 37. Endogenous cardiotonic steroids in chronic renal failure.
    Kolmakova EV, Haller ST, Kennedy DJ, Isachkina AN, Budny GV, Frolova EV, Piecha G, Nikitina ER, Malhotra D, Fedorova OV, Shapiro JI, Bagrov AY.
    Nephrol Dial Transplant; 2011 Sep 12; 26(9):2912-9. PubMed ID: 21292813
    [Abstract] [Full Text] [Related]

  • 38. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus.
    Bagrov YY, Manusova NB, Egorova IA, Fedorova OV, Bagrov AY.
    Front Biosci; 2005 Sep 01; 10():2257-62. PubMed ID: 15970492
    [Abstract] [Full Text] [Related]

  • 39. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.
    Averina IV, Tapilskaya NI, Reznik VA, Frolova EV, Fedorova OV, Lakatta EG, Bagrov AY.
    Cell Mol Biol (Noisy-le-grand); 2006 Dec 30; 52(8):19-23. PubMed ID: 17535731
    [Abstract] [Full Text] [Related]

  • 40. Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C.
    Barman SA.
    Am J Physiol Lung Cell Mol Physiol; 2007 Aug 30; 293(2):L472-9. PubMed ID: 17468135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.